doxazosin has been researched along with Complication, Postoperative in 16 studies
Doxazosin: A prazosin-related compound that is a selective alpha-1-adrenergic blocker.
doxazosin : A member of the class of quinazolines that is quinazoline substituted by an amino group at position 4, methoxy groups at positions 6 and 7 and a piperazin-1-yl group at position 2 which in turn is substituted by a 2,3-dihydro-1,4-benzodioxin-2-ylcarbonyl group at position 4. An antihypertensive agent, it is used in the treatment of high blood pressure.
Excerpt | Relevance | Reference |
---|---|---|
"No conclusion exists for the optimum duration of preoperative administration of doxazosin (DOX) before adrenalectomy for pheochromocytoma." | 7.96 | The use of doxazosin before adrenalectomy for pheochromocytoma: is the duration related to intraoperative hemodynamics and postoperative complications? ( Bao, Z; Fang, D; Gao, Y; Jin, B; Kong, H; Li, N; Liu, L; Tian, J; Wu, K; Zhang, J; Zhang, Z; Zhou, L, 2020) |
"To compare phenoxybenzamine (PhB) and doxazosin (DOX) in terms of perioperative haemodynamic status in patients with pheochromocytoma, who have been prepared for adrenalectomy." | 7.85 | Comparison of phenoxybenzamine and doxazosin in perioperative management of patients with pheochromocytoma. ( Ambroziak, U; Bednarczuk, T; Gałązka, Z; Kącka, A; Krajewska, E; Malec, K; Miśkiewicz, P; Piotrowski, M; Toutounchi, S; Witkowska, A, 2017) |
"Doxazosin GITS is a safe agent which can reduce cardiovascular risk." | 6.71 | Doxazosin GITS trough to peak ratio and 24-hour blood pressure monitoring in the management of hypertension in renal transplant patients. ( Grinyó, JM; Ibernón, M; Martínez Castelao, A; Moreso, F; Rama, I; Sanz, V; Sarrias, X, 2003) |
"No conclusion exists for the optimum duration of preoperative administration of doxazosin (DOX) before adrenalectomy for pheochromocytoma." | 3.96 | The use of doxazosin before adrenalectomy for pheochromocytoma: is the duration related to intraoperative hemodynamics and postoperative complications? ( Bao, Z; Fang, D; Gao, Y; Jin, B; Kong, H; Li, N; Liu, L; Tian, J; Wu, K; Zhang, J; Zhang, Z; Zhou, L, 2020) |
"To compare phenoxybenzamine (PhB) and doxazosin (DOX) in terms of perioperative haemodynamic status in patients with pheochromocytoma, who have been prepared for adrenalectomy." | 3.85 | Comparison of phenoxybenzamine and doxazosin in perioperative management of patients with pheochromocytoma. ( Ambroziak, U; Bednarczuk, T; Gałązka, Z; Kącka, A; Krajewska, E; Malec, K; Miśkiewicz, P; Piotrowski, M; Toutounchi, S; Witkowska, A, 2017) |
" Laboratory tests were performed, adverse events recorded, and prostatic symptomatology examined." | 2.71 | Efficacy and safety of doxazosin GITS in hypertensive renal transplant patients: comparison of 8 and 4 mg. ( Hurtado, S; Lloveras, J; Oliveras, A; Puig, JM; Vázquez, S, 2003) |
"Doxazosin GITS is a safe agent which can reduce cardiovascular risk." | 2.71 | Doxazosin GITS trough to peak ratio and 24-hour blood pressure monitoring in the management of hypertension in renal transplant patients. ( Grinyó, JM; Ibernón, M; Martínez Castelao, A; Moreso, F; Rama, I; Sanz, V; Sarrias, X, 2003) |
"In conclusion, intraoperative complications in pheochromocytoma surgery are common and can be potentially life-threatening." | 1.62 | Risk factors for intraoperative complications in pheochromocytomas. ( Álvarez-Escolá, C; Araujo-Castro, M; Blanco-Carrera, C; Calatayud Gutiérrez, M; de Miguel Novoa, P; Fernández-Ladreda, MT; Garcia Centeno, R; Gómez Dos Santos, V; Gracia Gimeno, P; Hanzu, FA; Lamas, C; López-García, MC; Mínguez Ojeda, C; Mora, M; Percovich Hualpa, JC; Serrano Romero, A; Valdés, N; Vidal, Ó, 2021) |
"The patient demonstrated marked orthostatic hypotension without increment of heart rate, increased variability of blood pressure and abnormal hypertensive surges in a single 24 hour period, and abnormal response of heart rate during Valsalva's maneuver." | 1.34 | [Case of baroreflex failure after bilateral revascularization of the cervical carotid artery]. ( Azuma, Y; Imai, K; Makino, M; Niwa, F; Oda, K; Oshima, F, 2007) |
"Sirolimus is an immunosuppressive drug which has proved its effectivity to reduce the incidence of acute rejection in renal transplantation receptors." | 1.32 | [Interstitial pneumonitis associated with sirolimus administration in a renal transplantation patient: a clinical case]. ( Gentil, MA; González Roncero, FM; López, M; Martínez, M; Mateos, J; Pereira, P; Rodríguez Algarra, G; Toro, J; Valdivia, MA, 2004) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (6.25) | 18.2507 |
2000's | 8 (50.00) | 29.6817 |
2010's | 3 (18.75) | 24.3611 |
2020's | 4 (25.00) | 2.80 |
Authors | Studies |
---|---|
Kong, H | 1 |
Li, N | 1 |
Tian, J | 1 |
Bao, Z | 1 |
Liu, L | 1 |
Wu, K | 1 |
Gao, Y | 1 |
Jin, B | 1 |
Zhang, Z | 1 |
Fang, D | 1 |
Zhang, J | 1 |
Zhou, L | 1 |
Iglesias, P | 1 |
Santacruz, E | 1 |
García-Sancho, P | 1 |
Marengo, AP | 1 |
Guerrero-Pérez, F | 1 |
Pian, H | 1 |
Fajardo, C | 1 |
Villabona, C | 1 |
Díez, JJ | 1 |
Araujo-Castro, M | 1 |
Garcia Centeno, R | 1 |
López-García, MC | 1 |
Lamas, C | 1 |
Álvarez-Escolá, C | 1 |
Calatayud Gutiérrez, M | 1 |
Blanco-Carrera, C | 1 |
de Miguel Novoa, P | 1 |
Valdés, N | 1 |
Gracia Gimeno, P | 1 |
Fernández-Ladreda, MT | 1 |
Mínguez Ojeda, C | 1 |
Percovich Hualpa, JC | 1 |
Mora, M | 1 |
Vidal, Ó | 1 |
Serrano Romero, A | 1 |
Hanzu, FA | 1 |
Gómez Dos Santos, V | 1 |
Zheng, Y | 1 |
Bai, F | 1 |
Zhang, N | 1 |
Wu, H | 1 |
Malec, K | 1 |
Miśkiewicz, P | 1 |
Witkowska, A | 1 |
Krajewska, E | 1 |
Toutounchi, S | 1 |
Gałązka, Z | 1 |
Piotrowski, M | 1 |
Kącka, A | 1 |
Bednarczuk, T | 1 |
Ambroziak, U | 1 |
Drzayich Antol, D | 1 |
Waldman Casebeer, A | 1 |
Khoury, R | 1 |
Michael, T | 1 |
Renda, A | 1 |
Hopson, S | 1 |
Parikh, A | 1 |
Stein, A | 1 |
Costantino, M | 1 |
Stemkowski, S | 1 |
Bunce, M | 1 |
Nevo, N | 1 |
Abu-Abeid, S | 1 |
Hazzan, D | 1 |
Lahat, G | 1 |
Nachmani, I | 1 |
Eldar, SM | 1 |
Zhang, L | 1 |
Xia, X | 1 |
Zhong, Y | 1 |
Xie, D | 1 |
Liu, S | 1 |
Wang, X | 1 |
Tu, J | 1 |
Faconti, L | 1 |
Mills, CE | 1 |
Govoni, V | 1 |
Gu, H | 1 |
Morant, S | 1 |
Jiang, B | 1 |
Cruickshank, JK | 1 |
Webb, AJ | 1 |
Lin, J | 1 |
Wu, YJ | 1 |
Liang, X | 1 |
Ji, M | 1 |
Ying, HM | 1 |
Wang, XY | 1 |
Sun, X | 1 |
Shao, CH | 1 |
Zhan, LX | 1 |
Zhang, Y | 2 |
Czamara, K | 1 |
Karnas, E | 1 |
Majka, Z | 1 |
Wojcik, T | 1 |
Zuba-Surma, EK | 1 |
Baranska, M | 1 |
Kaczor, A | 1 |
Liu, X | 1 |
Zhou, F | 1 |
Yang, Y | 2 |
Wang, W | 1 |
Niu, L | 1 |
Zuo, D | 1 |
Li, X | 1 |
Hua, H | 1 |
Zhang, B | 1 |
Kou, Y | 1 |
Guo, J | 1 |
Kong, F | 1 |
Pan, W | 1 |
Gao, D | 1 |
Meves, JM | 1 |
Sun, H | 1 |
Xue, M | 1 |
Zhang, Q | 1 |
Wang, Y | 2 |
Tang, R | 1 |
Iso, T | 1 |
Haruyama, H | 1 |
Sunaga, H | 1 |
Matsui, H | 1 |
Matsui, M | 1 |
Tanaka, R | 1 |
Umbarawan, Y | 1 |
Syamsunarno, MRAA | 1 |
Putri, M | 1 |
Yamaguchi, A | 1 |
Hanaoka, H | 1 |
Negishi, K | 1 |
Yokoyama, T | 1 |
Kurabayashi, M | 1 |
Palomo-Briones, R | 1 |
Esquivel-González, S | 1 |
Aizpuru, A | 1 |
Gómez-Hernández, N | 1 |
Casas-Flores, S | 1 |
Barba de la Rosa, AP | 1 |
Arriaga, S | 1 |
Peterson, ME | 1 |
Carothers, MA | 1 |
Gamble, DA | 1 |
Rishniw, M | 1 |
Zhang, P | 1 |
Zhang, XD | 1 |
Shao, Y | 1 |
Chen, R | 1 |
Shen, ZJ | 1 |
Teng, Y | 1 |
Huang, P | 1 |
Rui, WB | 1 |
Xie, X | 1 |
Zhou, WL | 1 |
Merrick, GS | 1 |
Butler, WM | 1 |
Wallner, KE | 1 |
Lief, JH | 1 |
Galbreath, RW | 1 |
Oliveras, A | 1 |
Hurtado, S | 1 |
Vázquez, S | 1 |
Puig, JM | 1 |
Lloveras, J | 1 |
Martínez Castelao, A | 1 |
Ibernón, M | 1 |
Sarrias, X | 1 |
Sanz, V | 3 |
Moreso, F | 1 |
Rama, I | 1 |
Grinyó, JM | 3 |
Martínez, M | 1 |
González Roncero, FM | 1 |
López, M | 1 |
Toro, J | 1 |
Valdivia, MA | 1 |
Pereira, P | 1 |
Gentil, MA | 1 |
Rodríguez Algarra, G | 1 |
Mateos, J | 1 |
Azuma, Y | 1 |
Imai, K | 1 |
Oda, K | 1 |
Niwa, F | 1 |
Makino, M | 1 |
Oshima, F | 1 |
Martínez-Castelao, A | 2 |
Hueso, M | 2 |
Rejas, J | 2 |
Alsina, J | 2 |
Blanchard, K | 1 |
Hananel, A | 1 |
Rutchik, S | 1 |
Sullivan, J | 1 |
Sarrias, J | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
A Pilot Study for Randomized Controlled Trial on the Effect and Safety of Omitting Preoperative Alpha-adrenergic Blockade for Normotensive Pheochromocytoma[NCT05702944] | Phase 4 | 24 participants (Anticipated) | Interventional | 2023-01-18 | Recruiting | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
6 trials available for doxazosin and Complication, Postoperative
Article | Year |
---|---|
Topics: Adult; Aged; Animals; Astrocytes; Bariatric Surgery; Beta vulgaris; Bioreactors; Biotechnology; Bloo | 2018 |
Prophylactic versus therapeutic alpha-blockers after permanent prostate brachytherapy.
Topics: Adenocarcinoma; Adrenergic alpha-Antagonists; Biopsy; Brachytherapy; Doxazosin; Follow-Up Studies; H | 2002 |
Efficacy and safety of doxazosin GITS in hypertensive renal transplant patients: comparison of 8 and 4 mg.
Topics: Adrenergic alpha-Antagonists; Antihypertensive Agents; Blood Pressure; Cross-Over Studies; Dose-Resp | 2003 |
Doxazosin GITS trough to peak ratio and 24-hour blood pressure monitoring in the management of hypertension in renal transplant patients.
Topics: Antihypertensive Agents; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Doxazosin; Female; H | 2003 |
Treatment of hypertension after renal transplantation: long-term efficacy of verapamil, enalapril, and doxazosin.
Topics: Adult; Antihypertensive Agents; Calcium Channel Blockers; Doxazosin; Enalapril; Female; Follow-Up St | 1998 |
Double-blind, crossover, comparative study of doxazosin and enalapril in the treatment of hypertension in renal transplant patients under cyclosporine immunosuppression.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Glucose; Blood Press | 2002 |
10 other studies available for doxazosin and Complication, Postoperative
Article | Year |
---|---|
The use of doxazosin before adrenalectomy for pheochromocytoma: is the duration related to intraoperative hemodynamics and postoperative complications?
Topics: Adrenal Gland Neoplasms; Adrenalectomy; Adrenergic alpha-1 Receptor Antagonists; Adult; Aged; Doxazo | 2020 |
Pheochromocytoma: A three-decade clinical experience in a multicenter study.
Topics: 3-Iodobenzylguanidine; Adolescent; Adrenal Gland Neoplasms; Adrenergic alpha-Antagonists; Adult; Age | 2021 |
Risk factors for intraoperative complications in pheochromocytomas.
Topics: Adrenal Gland Neoplasms; Adrenalectomy; Adult; Aged; Doxazosin; Female; Humans; Hydrocortisone; Hypo | 2021 |
Analysis of Voiding Impairment after Prostate Biopsy and the Effect of Doxazosin Treatment: Outcomes from a Regional Cancer Center.
Topics: Adrenergic alpha-1 Receptor Antagonists; Aged; Doxazosin; Humans; Image-Guided Biopsy; Male; Postope | 2022 |
Comparison of phenoxybenzamine and doxazosin in perioperative management of patients with pheochromocytoma.
Topics: Adrenalectomy; Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Blood Pressure; Disease Mana | 2017 |
Extended-release doxazosin for treatment of renal transplant recipients with benign prostatic hyperplasia.
Topics: Adrenergic alpha-Antagonists; Aged; Blood Urea Nitrogen; Delayed-Action Preparations; Doxazosin; Fam | 2009 |
Preoperative alpha blockade for normotensive pheochromocytoma: is it necessary?
Topics: Adrenal Gland Neoplasms; Adrenalectomy; Adrenergic alpha-Antagonists; Adult; Blood Pressure; Doxazos | 2011 |
[Interstitial pneumonitis associated with sirolimus administration in a renal transplantation patient: a clinical case].
Topics: Aged; Antilymphocyte Serum; Azathioprine; Cyclosporine; Diagnosis, Differential; Diuretics; Doxazosi | 2004 |
[Case of baroreflex failure after bilateral revascularization of the cervical carotid artery].
Topics: Adrenergic alpha-Antagonists; Aged; Baroreflex; Carotid Artery, Internal; Carotid Stenosis; Diagnosi | 2007 |
Transurethral resection of the prostate: failure patterns and surgical outcomes in patients with symptoms refractory to alpha-antagonists.
Topics: Adrenergic alpha-Antagonists; Aged; Comorbidity; Doxazosin; Humans; Louisiana; Male; Postoperative C | 2000 |